Zebrafish PDX
Explore our latest news articles on how our contract research organization accelerates pre-clinical drug development.
New publication: ZTX® in vivo data contribute to the preclinical evaluation of Telomir-Zn in triple-negative breast cancer
BioReperia Presents ASCO Poster Showcasing the ZTX® Platform for Late Preclinical Drug Development
BioReperia provides key in vivo validation in AML study published in Leukemia
New article published
Zebrafish predict treatment in lungcancer
On-demand webinar
Zebrafish PDX model as screening tool – AACR 2020